This discussion paper and vision statement calls for a single pharmacist & GP practice for each care home describing the context of major medication safety challenges in care homes.
Studies report a reduction in inappropriate polypharmacy, errors, and cost achieved by pharmacist input in care homes. In addition, a pharmacist can identify gaps and lead on targeted actions in key therapeutic areas to support the provision of high quality care and safety for care home residents.
This document, produced by Aneurin Bevan Health Board, outlines a review process for patients on 10 or more medications. It includes the NO TEARS tool to aid medication review and includes locally developed review processes.
Good Practice Case Study. Angus’ multidisciplinary medication review service for older people - NHS Tayside
This case study illustrates an example of innovative practice to improve medication safety in older people. The team from Tayside in Scotland introduced a collaborative multidisciplinary approach to medication review, which led to a reduction in polypharmacy, improved patient understanding of treatment, and prescribing cost savings.
Care homes' use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people
This important, large study of care home residents identified a high incidence of medication errors in care home residents and explores underlying reasons and potential solutions for these.
This improvement report documents the development of a medication review tool, based on the evidence based “STOPP” (screening tool of older persons’ potentially inappropriate prescriptions) for routine use with elderly patiens across all sections of care.
Improving medication safety for people in care homes: thoughts and experiences from carers and relatives
This report from the Health Foundation collects together the testimony given by family and carers of people living in a care home, specifically around issues of medication safety.
This paper defines our current understanding of appropriate prescribing and outlines the potential hazards of over-prescribing for older people, while acknowledging the benefits of modern pharmacological treatment.